Download PDF
Thromb Haemost 1993; 70(05): 873-875
DOI: 10.1055/s-0038-1649686
Fibrinolysis
Schattauer GmbH Stuttgart

Parameters of Fibrinolysis in Peritoneal Fluid and Plasma in Different Stages of the Menstrual Cycle

P J Dörr
1   The Department of Obstetrics and Gynaecology, Westeinde Hospital, The Hague, The Netherlands
,
E J P Brommer
2   The Gaubius Laboratory-IVVO, Health Research Division TNO, Leiden, The Netherlands
,
G Dooijewaard
2   The Gaubius Laboratory-IVVO, Health Research Division TNO, Leiden, The Netherlands
,
H M Vemer
3   The Department of Obstetrics and Gynaecology, St. Radboud University Hospital, Nijmegen, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 08 April 1993

Accepted after revision 30 June 1993

Publication Date:
05 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The purpose of this study was to investigate differences in fibrinolytic activity in peritoneal fluid and plasma of women in the first and second part of the menstrual cycle. Given the classic concept of decreased fibrinolytic activity as a cause of adhesion formation, and if such differences are found, the stage of women’s menstrual cycle should be taken into consideration when scheduling a laparotomy.

We measured fibrinolytic parameters in peritoneal fluid and plasma in eight women in the pre-ovulatory period and in eleven women in the post-ovulatory period of the menstrual cycle.

There were no differences in t-PA-Ag, t-PA-Act, u-PA-Ag and scu-PA concentrations in peritoneal fluid between the pre- and post-ovulatory group. Nevertheless, PAI-1-Ag in peritoneal fluid was three-fold higher in the post-ovulatory phase (p <0.02). In peritoneal fluid the concentrations of both TDP and FbDP were three-fold higher at the same phase (p ≥0.05).

Plasma u-PA-Ag and scu-PA concentrations were significantly lower (30%, p <0.05) in the post-ovulatory phase and also lower than plasma u-PA-Ag and scu-PA (measured with the same assay) in a group of 50 healthy individuals. No differences in t-PA and PAI concentration were found.

In conclusion, the intraperitoneal fibrinolytic capacity might be impaired in the second part of the menstrual cycle, regarding the elevated levels of PAI-1-Ag, leading to an increased risk for postovulatory adhesion formation. The low plasma u-PA-Ag and scu- PA levels post-ovulatory may have clinical relevance.

 

  • References

  • 1 Diamond E. Lysis of postoperative pelvic adhesions in infertility. Fertil Steril 1979; 31: 287-295
    CrossrefPubMedGoogle Scholar
  • 2 McEntee G, Pender D, Mulvin D, McCullough M. et al. Current spectrum of intestinal obstruction. Br J Surg 1987; 74: 976-980
    CrossrefPubMedGoogle Scholar
  • 3 Ellis H, Harrison W, Hugh TB. The healing of peritoneum under normal and pathological conditions. Br J Surg 1965; 52: 471-476
    CrossrefPubMedGoogle Scholar
  • 4 Myhre-Jensen O, Bergman-Larsen S, Astrup T. Fibrinolytic activity in serosal and synovial membranes. Arch Pathol 1969; 88: 623-630
    PubMedGoogle Scholar
  • 5 Porter JM, McGregor FJr, Mullen DC. et al. Fibrinolytic activity of mesothelial surfaces. Surg Forum 1969; 20: 080-082
    PubMedGoogle Scholar
  • 6 Thompson JN, Paterson-Brown S, Harbourne T, Whawell SA, Kalodki E, Dudley HAF. Reduced human plasminogen activating activity: possible mechanism of adhesion formation. Br J Surg 1989; 76: 382-384
    CrossrefPubMedGoogle Scholar
  • 7 Vipond MN, Whawell SA, Thompson JN, Dudley HAF. Peritoneal fibrinolytic activity and intraperitoneal adhesions. Lancet 1990; 335: 1120-1122
    CrossrefPubMedGoogle Scholar
  • 8 Dörr PJ, Brommer EJP, Dooijewaard G, Vemer HM. Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease. Thromb Haemostas 1992; 68: 102-105
    PubMedGoogle Scholar
  • 9 Beers WH. Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall. Cell 1975; 6: 379-386
    CrossrefPubMedGoogle Scholar
  • 10 Strickland S, Beers WH. Studies on the role of plasminogen activator in ovulation. J Biol Chem 1976; 251: 5694-5701
    PubMedGoogle Scholar
  • 11 Espey LL. Ovarian proteolytic enzymes and ovulation. Biol Reprod 1974; 10: 216-235
    CrossrefPubMedGoogle Scholar
  • 12 Ny T, Bjersing L, Hsueh AJW, Loskutoff DJ. Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins. Endocrinology 1985; 116: 1666-1668
    CrossrefPubMedGoogle Scholar
  • 13 Wang C, Leung A. Gonadotropins regulate plasminogen activator production by rat granulosa cells. Endocrinology 1983; 112: 1201-1207
    CrossrefPubMedGoogle Scholar
  • 14 Yi-Xun Liu, Cajander SB, Tor Ny, Kristensen P, Hsueh AJW. Gonadotropin regulation of tissue-type and urokinase-type plasminogen activators in rat granulosa and theca-interstitial cells during the periovulatory period. Mol Cell Endocrinol 1987; 54: 221-229
    CrossrefPubMedGoogle Scholar
  • 15 Hsueh AJW, Yi-Xun Liu, Cajander S, Xiao-Rong Peng, Dahl K, Kristensen P, Tor Ny. Gonadotropin-Releasing Hormone induces ovulation in hypophysectomized rats: studies on ovarian tissue-type plasminogen activator activity, messenger ribonucleic acid content, and cellular localization. Endocrinology 1988; 122: 1486-1495
    CrossrefPubMedGoogle Scholar
  • 16 Maathuis JB, Look PFAv, Michie EA. Changes in volume, total protein and ovarian steroid concentrations of peritoneal fluid through out the human menstrual cycle. J Endocrinol 1978; 76: 123-133
    CrossrefPubMedGoogle Scholar
  • 17 Bouckaert PXJM, Evers JLH, Doesburg WH, Schellekens LA, Rolland R. Patterns of changes in glycoproteins, polypeptides, and steroids in the peritoneal fluid of women during the periovulatory phase of the menstrual cycle. J Clin Endocrinol Metab 1986; 62: 239-243
    PubMedGoogle Scholar
  • 18 Pattinson HA, Koninckx PR, Brosens IA. Clotting and fibrinolytic activities in peritoneal fluid. Br J Obstet Gynaecol 1981; 88: 160-166
    CrossrefPubMedGoogle Scholar
  • 19 Bouckaert PXJM, Wersch JWJv, Schellekens LA, Evers JLH, Rolland R. Haemostatic and fibrinolytic properties of peritoneal fluid in the menstrual cycle. Br J Obstet Gynaecol 1984; 91: 256-259
    CrossrefPubMedGoogle Scholar
  • 20 Dunselman GA, Bouckaert PXJM, Wersch JWv, Brommer EJ, Evers JL. Fibrinolytic properties of peritoneal fluid in endometriosis. Gynecol Obstet Invest 1988; 26: 302-307
    CrossrefPubMedGoogle Scholar
  • 21 Padilla SL, Galle PC, Ellegood JO, Mahesh VB, McDonough PG. Plasminogen in peritoneal fluid: a possible nonsteroidal indicator of ovulation. Fertil Steril 1986; 46: 1071-1076
    CrossrefPubMedGoogle Scholar
  • 22 Verheijen JH, Chang CTG, Kluft C. Evidence for the occurrence of a fast acting inhibitor of tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
    PubMedGoogle Scholar
  • 23 Binnema D, Van IerselJJL, Dooijewaard G. Quantitation of urokinase antigen in plasma and culture media by use of an ELISA. Thromb Res 1986; 43: 569-577
    CrossrefPubMedGoogle Scholar
  • 24 Hinsbergh VWMv, Berg EAvd, Fiers W, Dooijewaard G. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 1990; 75: 1991-1998
    PubMedGoogle Scholar
  • 25 Bouckaert PXJM, Land JA, Brommer EJP, Emeis JJ, Evers JLH. The impact of peritoneal trauma on intra-abdominal fibrinolytic activity, adhesion formation and early embryonic development in a rabbit longitudinal model. Hum Reprod 1990; 5 (03) 237-241
    CrossrefPubMedGoogle Scholar
  • 26 Dooijewaard G, Iersel JJCv, Brommer EJP. Quantitation of pro-UK, UK and UK-inhibitor levels in plasma of patients and healthy men. In: Abstracts of the Eighth International Congress on Fibrinolysis, Vienna 1986. Binder BR. (ed) Edinburgh: Churchill Livingstone; 1986: 142
    Google Scholar
  • 27 Levi M, Cate JWten, Dooijewaard G, Sturk A, Brommer EJP, Agnelli G. DDAVP induces systemic release of urokinase-type plasminogen activator. Thromb Haemostas 1989; 62: 686-689
    PubMedGoogle Scholar
  • 28 Dooijewaard G, Boer Ad, Turion PNC, Cohen AF, Breimer DD, Kluft C. Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma. Thromb Haemostas 1991; 65: 082-086
    PubMedGoogle Scholar
  • 29 Koh SLC, Yuen R, Viegas OAC, Chua SE, Ng BL, Den DK, Ratnam SS. Plasminogen activators t-PA, u-PA and its inhibitor in normal males and females. Thromb Haemostas 1991; 66: 581-585
    PubMedGoogle Scholar